Briar Capital Real Estate Fund LLC (www.BriarCapital.com) is pleased to announce the continued expansion of its business development team with the hiring of Jonathan “JD” Davis. Working out of Briar’s Houston corporate office, Davis will be responsible for sourcing new business in Texas and the Southwest United States as Vice President of Business Development.

Gambling.com Group Limited (Nasdaq: GAMB) (“Gambling.com Group” or the “Company”), a leading provider of player acquisition services for the regulated global online gambling industry, today announced the closing of a new credit facility (the “Credit Facility”) with Wells Fargo Bank, National Association (“Wells Fargo”) in the principal amount of $50 million, comprised of a $25 million revolving credit facility and a $25 million term loan facility.

Finacity Corporation (“Finacity”), a White Oak Company, and Synovus Bank (“Synovus”) today announced that they have successfully arranged and closed a USD 30 million receivables-based loan program for Novaria Holdings LLC (“Novaria”), a leading manufacturer of specialty aerospace hardware.

TAB Bank announced today the promotion of Terri Lins as Chief Credit Officer, effective immediately. Lins has been an integral part of the TAB Bank team for more than a decade, most recently serving as Senior Vice President and Senior Credit Officer.

Monroe Capital LLC (“Monroe”) today announced it has expanded its platform to the Middle East with the appointment of Waleed Noor as Managing Director and Head of Middle East Distribution. Monroe is in the process of opening an office in Abu Dhabi. Mr. Noor will be based in Abu Dhabi and be responsible for representing Monroe throughout the region.

A deal team from Haynes and Boone, LLP advised BiomX Inc. (NYSE: PHGE) in its merger with Adaptive Phage Therapeutics, Inc. (APT) and the concurrent $50 million private placement financing. The merger created an impactful phage therapy company with a robust pipeline, featuring two Phase 2 assets targeting chronic pulmonary infections in cystic fibrosis patients and diabetic foot osteomyelitis.

Allison Transmission Holdings Inc. (NYSE: ALSN) (“Allison” or the “Company”) announced today that, on March 13, 2024, its wholly owned subsidiary, Allison Transmission, Inc. (the “Borrower”), entered into a fourth amendment to its credit agreement (the “Amendment”).

Kyte (https://kyte.com), the company pioneering cars delivered to you on-demand, today announced the closing of an asset-backed credit financing of up to $250 million from Barclays Bank ("Barclays") and Waterfall Asset Management ("Waterfall") to accelerate the company's fleet growth and profitability.

Holland & Knight advised DifGen Pharmaceuticals LLC on its all-cash purchase, through its subsidiary Aveva Drug Delivery Systems Inc., of the operating and manufacturing assets of a U.S. Food and Drug Administration (FDA)-registered manufacturing facility owned by New Vision Pharmaceuticals and located in Tamarac, Florida.

Huntington Business Credit announced it closed a $45,000,000 new credit facility with SDB Trade International, LLC on February 16, 2024. Proceeds of the facility were used to refinance existing debt and provide ongoing working capital financing.

UpField Financial, LLC ("UpField"), a financial diligence and consulting firm, announced that Brian Rush, CPA, has joined the firm as a Partner— focused on lender due-diligence and specializing in providing collateral exams, desktop reviews, portfolio reviews and quality of earnings reports for commercial banks and non-bank lenders in their Commercial, Corporate, and Asset-based Groups.

B. Riley Securities, Inc. ("B. Riley"), a leading middle market investment bank, is pleased to have served as the Lead Left Bookrunner in connection with Landsea Homes Corporation's (Nasdaq: LSEA) (“Landsea” or the "Company”) recent $32.5 million secondary offering. B. Riley led the sale of 2,800,000 shares of the Company’s common stock at a public offering price of $11.60 by Landsea Holdings Corporation (“Selling Stockholder”).

Reitman provides clients with legal, regulatory and business advice on commodities. She has more than 25 years’ experience in commodity markets and more than 18 years of senior management experience, with a particular focus on energy, metals, agriculture, carbon and other sustainable commodities.

Drilling Tools International Corp. (NASDAQ: DTI) ("DTI" or the "Company"), a global oilfield services company that manufactures and provides a differentiated, rental-focused offering of tools for use in onshore and offshore horizontal and directional drilling operations, today announced that it has completed an amendment (the "ABL Amendment") to its existing Amended and Restated Senior Secured Asset-Based Revolving Credit, Security And Guaranty Agreement, with PNC Business Credit, a division of PNC Bank, National Association (the "ABL Credit Facility").

Today, KeyCorp (NYSE: KEY, "Key") announced a forward flow origination partnership with Blackstone Credit & Insurance ("Blackstone") focused on Key's Specialty Finance Lending (SFL) group. SFL is a leading asset-based lender serving clients nationally across middle market, growth capital, transportation, equipment, and other verticals.

Comvest Partners (“Comvest”), a leading middle-market private equity and credit investment firm, today announced the final close of its sixth flagship private equity fund, Comvest Investment Partners VI, L.P. (“CIP VI”, or the “Fund”), with total capital commitments of $881 million.

Wintrust Receivables Finance (WRF) is happy to announce the closing of a new $15,000,000 account receivable line of credit for a well-established Midwest-based third-party logistics firm.

ccord Financial Corp. (“Accord” or the “Company”) (TSX – ACD) today announced that it has entered into amendments to its primary credit facility with its banking syndicate. As disclosed in its third quarter report, in November 2023, the Company uncovered significant irregularities in collateral reporting by a borrower related to a $14.4 million loan, which led the Company to record a specific provision for credit losses relating to this loan.

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today announced that it has entered into a $175 million five-year, term loan facility with Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”). The transaction strengthens the Company’s balance sheet as it executes on the commercial launches for its three FDA approved gene therapies – LYFGENIA for sickle cell disease, ZYNTEGLO for beta-thalassemia and SKYSONA for cerebral adrenoleukodystrophy.

Businesses dealing in lower-priced, lower margin products typically need to sell higher volumes to turn a profit. Financing exports can facilitate large enough shipments to achieve profitability in these cases.